Market Intelligence Report

Infection Surveillance Systems Market
Strategic Industry Analysis and Competitive Outlook (2026–2032)

Category Biotechnology
Updated June 2026
Report Code PSMI-101
Formats PDF XLS Dashboard
Every licence includes 90 days of analyst support Questions, custom data cuts, and strategic follow-up included.
Built for Strategic Decision-Makers
Strategy & Corporate Development
Market entry evaluation, portfolio expansion, and growth mandate analysis
Companies shaping the market
Competitive due diligence, target screening, and sector risk assessment
Go-to-Market Teams
Pricing benchmarking, segment prioritisation, and demand forecasting
Profshare Research Team
Last reviewed: June 2026 · Senior Market Analysts · Biotechnology
12+ Companies Profiled
22+ Countries Covered
150+Sources Per Report
5-StageValidation Process
95%Client Satisfaction
IndependentPeer Review
Used by industry leaders in Pharma & Healthcare · Energy · Chemicals · Automotive · Semiconductor & Electronics
This report enables you to →
Benchmark Key Players
Identify Growth Opportunities
Analyse Pricing Economics
Assess Regional Demand
Drive Strategic Decisions
Market Size (2026)
USD 575.5 Million
Base year
Market Size (2032)
USD 2.04 Billion
Forecast year
CAGR (2026–2032)
15.1%
Compound annual growth
Dominant Region
North America
Largest market share
Geopolitical & Regulatory Risk Coverage

This report includes a dedicated chapter covering supply chain exposure, export controls, sanctions risk, and regulatory shifts affecting Infection Surveillance Systems Market.

Infection Surveillance Systems Market Strategic Outlook

Infection Surveillance Systems is designed to support decision making in infection prevention and control (IPC) programs by improving surveillance practices. Hospital-acquired infections (HAIs) have become serious concern globally. It occurs in at least 48 hours into a patient’s hospital stay that were neither present nor incubating at the time of patient admission. HAIs are critical safety concerns for patients, healthcare professionals and healthcare systems. Infection surveillance system has emerged as support to evidence-based prevention and control programs to reduce HAI prevalence.  


Market Forecast 2026–2032

⬇ Download Chart
Infection Surveillance Systems Market forecast CAGR 15.1% 2026–2032
Global Infection Surveillance Systems Market Revenue Forecast (USD Million), 2026–2032. Valued at USD 575.5 Million (2026), projected to USD 2.04 Billion (2032). Source: Profshare Market Research.

Increasing occurrences of Hospital-acquired infections (HAIs) globally is main force driving Infection surveillance System Market. United States Infection surveillance System Market is expected to cross USD 600 million by 2024 holds almost 60% of market shares. Infection surveillance System is also emerging very rapidly in Europe, China, Japan, India and South Korea.  


Infection Surveillance Systems is need for accurate diagnosis of Hospital-acquired infections (HAIs). Infection surveillance systems information can inform prioritization of infection prevention efforts. World Health Organization (WHO) offers simplified definition of HAI to use in limited context for clinical diagnosis. United States Centers for Disease Control and Prevention (CDC) also offers standardized HAI definitions to follow in United States. A multi-disciplinary HAI steering committee has developed new Infection surveillance System which satisfies WHO definitions and collect accurate infection data. The use of electronic surveillance systems (ESSs) also used in many hospitals to control -acquired infections (HAIs).  


Infection Surveillance Systems on downside :

  • Requires prolonged surveillance
  • Varied majorly in accordance to treatment.
  • Challenging to implement in many low to middle-income countries (LMICs)
  • Microbiology laboratory and IT infrastructure requires
  • Patient records may be incomplete, inconsistent and hence unusable in Infection surveillance System.

Surgical site infections, which can occur up to thirty days post-operatively, may be difficult to conduct. These challenges may lead to non- or under-detection of HAI’s with resultant missed opportunities to institute the appropriate medical treatment. In LMICs prevalence of HAIs ranges from 5% to 70% among hospitalized patients, with surgical site infections being the most common. Highest HAI rates were found in intensive care unit (ICU), Neonatal ICU and Orthopedics / burn unit .  


Important applications of Infection Surveillance Systems:

  • Hospitals
  • Clinics
  • Home Cares
  • Sanitation

Global Infection Surveillance Systems Market: Product Type Analysis

  • Hardware
  • Software
  • Services

Global Infection Surveillance Systems Market: Solutions

    On Premise

  • Web Based
  • Training & Consulting
  • Implementation

Infection Surveillance Systems Market : Competitive Analysis

Report includes accurate analysis of key players with Market Value, Company profile, SWOT analysis. The Study consists of following key players in Infection surveillance System Market :

  • BD Medical
  • Premier
  • Wolters Kluwer
  • Baxter International
  • GOJO Industries
  • Atlas Medical Software
  • Deb Group
  • Hygreen
  • RL Solutions
  • Truven Health Analytics

Global Infection Surveillance Systems Market: Regional Analysis

  • North America
    • U.S.A
    • Canada
  • Europe
    • France
    • Germany
    • Spain
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South East Asia
  • Latin America
    • Brazil
  • Middle East and Africa

Report Coverage

ParameterDetails
Base Year2026
Historical Data2020 – 2025
Forecast Period2026 – 2032
Base Year ValueUSD 575.5 Million
Forecast ValueUSD 2.04 Billion
CAGR15.1%
Regional ScopeNorth America · Europe · Asia-Pacific · Latin America · MEA · RoW

Frequently Asked Questions

Infection Surveillance Systems Market was valued at USD 575.5 Million in 2026 and is estimated to reach USD 2.04 Billion by 2032.

Infection Surveillance Systems Market is projected to grow at a CAGR of 15.1% during 2026–2032, driven by rising demand across industrial and specialty applications.

United States Infection surveillance System Market is expected to reach USD 600 million by 2024 holds almost 60% of market shares.

Some of the top key players of the Infection Surveillance System Market are BD Medical,Premier,Wolters Kluwer,Baxter International,GOJO Industries,Atlas Medical Software,Deb Group,Hygreen,RL Solutions,Truven Health Analytics

Increasing occurrences of Hospital-acquired infections (HAIs) globally is main force driving Infection surveillance System Market.

Yes. The report includes a dedicated section on geopolitical risk factors and their impact on supply chains, pricing, and regional demand dynamics.

Request Free Sample

    Report Enquiry